About 26S proteasome regulatory subunit 6A
26S proteasome regulatory subunit 6A (PSMC3) is a protein
from Homo sapiens identified by UniProt accession
P17980, 439 residues long.
MolForge cross-references it against 0 known binders and
112 disease associations.
Target properties
| Protein name | 26S proteasome regulatory subunit 6A |
| UniProt accession | P17980 |
| Gene | PSMC3 |
| Organism | Homo sapiens |
| Length | 439 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (112)
Diseases linked to this target (Open Targets).
- Neurodevelopmental disorder · score 0.54
- neurodegenerative disease · score 0.52
- HIV infection · score 0.46
- Microcephaly · score 0.39
- scoliosis · score 0.37
- Acetabular dysplasia · score 0.37
- Global developmental delay · score 0.34
- developmental dysplasia of the hip · score 0.34
- Microretrognathia · score 0.34
- Cerebellar vermis hypoplasia · score 0.34
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P17980-F1 | alphafold | PREDICTED | 80.62 | — |
Amino-acid sequence (439 residues)
MNLLPNIESP VTRQEKMATV WDEAEQDGIG EEVLKMSTEE IIQRTRLLDS EIKIMKSEVL RVTHELQAMK DKIKENSEKI KVNKTLPYLV SNVIELLDVD PNDQEEDGAN IDLDSQRKGK CAVIKTSTRQ TYFLPVIGLV DAEKLKPGDL VGVNKDSYLI LETLPTEYDS RVKAMEVDER PTEQYSDIGG LDKQIQELVE AIVLPMNHKE KFENLGIQPP KGVLMYGPPG TGKTLLARAC AAQTKATFLK LAGPQLVQMF IGDGAKLVRD AFALAKEKAP SIIFIDELDA IGTKRFDSEK AGDREVQRTM LELLNQLDGF QPNTQVKVIA ATNRVDILDP ALLRSGRLDR KIEFPMPNEE ARARIMQIHS RKMNVSPDVN YEELARCTDD FNGAQCKAVC VEAGMIALRR GATELTHEDY MEGILEVQAK KKANLQYYA
Explore 26S proteasome regulatory subunit 6A with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets